Stroke
In cases of high comorbidity, clopiclogrel may be better choice than aspirin
Published in Cardiovascular Week, June 6th, 2005
According to the report from Germany, "Ischemic stroke and other atherothrombotic events substantially increase the medicoeconomic burden because of their high treatment costs and long-lasting disabilities with need for chronic care. Studies have shown that the cost of stroke represents approximately 3-5% of the annual health budget."
P.A. Ringleb and colleagues of the University of Heidelberg continued, "Antiplatelet agents play a major role in secondary stroke prevention. Acetylsalicylic acid (ASA), combined with extended-release...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2005-06-06)
More Articles from Cardiovascular Week
- Angiotensin
AT1 -Mas complex could be target for intervention in CV diseases - Cardiovascular Risk Factors
Occurrence of one CV risk factor may increase likelihood of others - Hyperlipidemia
Statins and n-3 fatty acids are the most favorable lipid-lowering interventions - Stents
Intraoperative stent placement avoids patch augmentation of pulmonary vessels - Addiction Medicine
Nicotinic acetylcholine receptor channel studied, subunit modulation shown - Alzheimer Disease
Study finds statin drugs can help treat Alzheimer disease - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
